for-phone-onlyfor-tablet-portrait-upfor-tablet-landscape-upfor-desktop-upfor-wide-desktop-up

Abcam Plc

ABCA.L

現在値

1,606.00GBp

変化

31.00(+1.97%)

出来高

580,390

本日のレンジ

1,566.00

 - 

1,611.00

52週レンジ

1,234.00

 - 

1,740.00

∙ 約20分前の相場を表示しています。

適時開示

Abcam Says Forex Headwind To HY Rev Growth Is Expected To Be About 6%

Sept 13 (Reuters) - Abcam PLC <ABCA.L>::H2 OPERATING PROFIT 10.3 MILLION STG VERSUS -16.1 MILLION STG LOSS YEAR AGO.H2 ADJUSTED OPERATING PROFIT ROSE 78 PERCENT TO 19.8 MILLION STG.TRADING PERFORMANCE YEAR-TO-DATE IS IN LINE WITH BOARD'S EXPECTATIONS, WITH MID-TEENS CER REVENUE GROWTH IN JULY AND AUGUST.FOREIGN EXCHANGE HEADWIND TO REVENUE GROWTH IS EXPECTED TO BE APPROXIMATELY 6% IN SIX MONTHS TO 31 DECEMBER 2021.REMAIN COMMITTED TO GENERATING REVENUE OF £425 - 500M FOR YEAR ENDING 31 DECEMBER 2024.ABCAM - LABORATORY ACTIVITY AND DEMAND HAVE CONTINUED TO GRADUALLY RECOVER AND TRADING PERFORMANCE YEAR-TO-DATE IS IN LINE WITH BOARD'S EXPECTATIONS.COMMITTED TO GENERATING REVENUE OF £425 - 500M FOR YEAR ENDING 31 DECEMBER 2024.ADJUSTED DEPRECIATION AND AMORTISATION ('D&A') COSTS OF APPROXIMATELY £17-18M ARE EXPECTED IN SIX MONTHS TO 30 DECEMBER 2021.EXCLUDING D&A, ADJUSTED COSTS AND EXPENSES FOR HY ENDED 31 DEC EXPECTED TO GROW AT MID- TO HIGH- SINGLE DIGIT OVER HY ENDED 30 JUNE 2021.

Abcam Says Sally W Crawford Appointed Non-Exec Director

Aug 13 (Reuters) - Abcam PLC <ABCA.L>::ABCAM PLC - DIRECTORATE CHANGE.APPOINTMENT OF SALLY W. CRAWFORD AS A NON-EXECUTIVE DIRECTOR .

Boai NKY Medical To Sell BioVision To Abcam

Aug 2 (Reuters) - Boai NKY Medical Holdings Ltd <300109.SZ>::SAYS UNIT AGREES TO SELL SPV THAT OWNS BIOVISION TO ABCAM US BY CASH.BOAI NKY MEDICAL SAYS BASIC VALUE FOR ITS SPV NKY US IS $342.9 MILLION.SAYS IT SIGNS STRATEGIC MOU WITH ABCAM PLC <<<ABCA.L>>>.

Abcam Plc Says HY Underlying Trading Modestly Ahead Of Board's Expectations

July 1 (Reuters) - Abcam PLC <ABCA.L>::ABCAM PLC - PRE-CLOSE TRADING UPDATE.ABCAM PLC - HY UNDERLYING TRADING HAS BEEN MODESTLY AHEAD OF BOARD'S EXPECTATIONS AND IN LINE WITH EXPECTATIONS AFTER CURRENCY MOVEMENTS.

Abcam Plc H1 Oper Profit Falls

March 8 (Reuters) - Abcam PLC <ABCA.L>::H1 ADJUSTED OPERATING PROFIT 23.6 MILLION STG VERSUS 33.4 MILLION STG YEAR AGO.H1 REVENUE 147.5 MILLION STG VERSUS 138.2 MILLION STG YEAR AGO.H1 OPERATING PROFIT 15.5 MILLION STG VERSUS 26.6 MILLION STG YEAR AGO.UPDATING OUR LONG-TERM OUTLOOK WITH A RANGE OF REVENUE OUTCOMES FOR END OF CALENDAR 2024 OF £425 - 500M.

Abingdon Health Says Signs Collaboration And Co-Marketing Agreement With Abcam

Feb 9 (Reuters) - Abingdon Health PLC <ABDX.L>::ABINGDON HEALTH PLC - COLLABORATION WITH ABCAM.ABINGDON HEALTH SIGNS COLLABORATION AND CO-MARKETING AGREEMENT WITH ABCAM.

Abcam Sees HY Gross Margin To Be In Line With Board Expectations

Jan 11 (Reuters) - Abcam PLC <ABCA.L>::ABCAM PLC - HALF YEAR TRADING UPDATE.ABCAM PLC - EXPECT TO REPORT TOTAL FIRST HALF REVENUE OF £147.5 MILLION (H1 2020: £138.2 MILLION).ABCAM PLC - HY GROSS MARGIN IS EXPECTED TO BE IN LINE WITH BOARD EXPECTATIONS AT APPROXIMATELY 70.5%, AHEAD OF FIRST HALF OF LAST YEAR.

Abcam PLC ADSs Open About 3% Above IPO Price In Debut

Oct 22 (Reuters) - Abcam PLC <ABCA.L>::ABCAM PLC ADSS OPEN AT $18 IN DEBUT ON NASDAQ VERSUS IPO PRICE OF $17.50 PER ADS.

Abcam Plc prices Offering Of 8.9 mln ADS At $17.50 Per ADS

Oct 22 (Reuters) - Abcam PLC <ABCA.L>::ABCAM PLC - PRICING OF OFFERING ON NASDAQ.ABCAM PLC - ANNOUNCES PRICING OF OFFERING OF 8.9 MILLION ADSS AT A PRICE OF $17.50 PER ADS, FOR AGGREGATE PROCEEDS OF ABOUT $156.5 MILLION.

Abcam Plc Commences Offering Of 8.9 mln American Depositary Shares

Oct 19 (Reuters) - Abcam PLC <ABCA.L>::ABCAM PLC - OFFERING AND APPLICATION TO LIST ON NASDAQ.ABCAM PLC - COMMENCEMENT OF REGISTERED OFFERING OF 8,945,218 AMERICAN DEPOSITARY SHARES, REPRESENTING AN AGGREGATE OF 8,945,218 ORDINARY SHARES.

金融情報はリフィニティブから。すべての情報は少なくとも20分遅れで表示されています。

for-phone-onlyfor-tablet-portrait-upfor-tablet-landscape-upfor-desktop-upfor-wide-desktop-up